SCHEMBL7235672

SCHEMBL7235672

COc1ccc(OC)c(-c2ccc(C(N)CC(=O)O)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CTSA P10619 8/20 0.50
FFAR1 O14842 7/20 0.46
HSD17B10 Q99714 1/20 0.46
TPH1 P17752 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20546204 0.86 CTSA (0.63) CTSA
SCHEMBL20546206 0.86 CTSA (0.63) CTSA
SCHEMBL20545888 0.84 CTSA (0.50) CTSATPH1
SCHEMBL20545890 0.84 CTSA (0.50) CTSATPH1
SCHEMBL20546209 0.84 CTSA (0.53) CTSAFFAR1
SCHEMBL20546211 0.84 CTSA (0.53) CTSAFFAR1
SCHEMBL20545218 0.83 CTSA (0.50) CTSAPTGDR2
SCHEMBL20545217 0.83 CTSA (0.50) CTSAPTGDR2
SCHEMBL7227941 0.83 MME (0.53) CTSA
SCHEMBL6607584 0.83 MME (0.53) CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed